Skip to main content Skip to navigation

News


Recurrent miscarriage: diabetes drug could lead to new treatment

A drug designed to tackle diabetes could also be repurposed as the first treatment to prevent miscarriage by targeting the lining of the womb itself, according to a clinical trial led by the University of Warwick

Thu 16 Jan 2020, 11:05

Artificial Intelligence (AI) detects low-glucose levels without fingerpick test

A new technology for detecting low glucose levels via ECG using a non-invasive wearable sensor, which with the latest Artificial Intelligence can detect hypoglycaemic events from raw ECG signals

Tue 14 Jan 2020, 14:41

MicrobeMeter Pro reaches prototype milestone

Humane Technologies Limited (HTL) has announced that it has successfully developed a prototype for the next generation of its microbial growth measurement device, the MicrobeMeter.


Ultra-fast new technology to detect bacteria launching at Lab Innovations

A discovery by University of Warwick spin-out company Cytecom offers a new technology for detecting bacteria in minutes by ‘zapping’ the bacteria with electricity.

Wed 30 Oct 2019, 15:48 | Tags: ICURe, spinout

Warwick spinout, Stoli Catalysts, wins €1.2m EIC grant

Stoli Catalysts, has been awarded €1.2m from the European Innovation Council (EIC) SME Instrument scheme to design, build and test a small-scale pilot plant to make medicines, vitamins and food supplements at much lower cost and more sustainably using its patented continuous flow catalytic reactor technology.

Fri 09 Aug 2019, 08:33

Freezing cells made safer thanks to new polymer

A new cryoprotectant polymer that dramatically improves the freezing of cells, has been discovered by researchers at the University of Warwick. The new polymers can reduce the amount of organic solvent required in cryopreservation (freezing cells) as well as giving more and healthier cells after thawing. Findings may help reduce cost and improve distribution of cells for cell-based therapies, diagnostics and research

Mon 05 Aug 2019, 09:51 | Tags: Chemistry, Life Sciences and Biotechnology, medical

New CEO for Warwick Spin-out Medherent

Medherent Ltd, developer of the TEPI© Patch drug delivery technology, has appointed John Burt as its new CEO

Tue 25 Jun 2019, 12:56

Disruptive 2D mass spectrometry spin-out secures seed investment

Verdel Instruments Ltd - a spin-out company of the University of Warwick UK – has developed new disruptive two-dimensional mass spectrometry (2DMS) technology and raised seed investment of over £230,000 from Longwall Ventures and Innovate UK.

Fri 31 May 2019, 11:01 | Tags: Warwick Ventures, funding, spinout

£1m Funding Award to Improve Primary Care using AI

Warwick University spinout, Spectra Analytics, has been awarded £1m by Innovate UK to improve Primary Care using AI

Thu 30 May 2019, 13:24 | Tags: Warwick Ventures, funding, spinout

Major Investment for Medherant

Medherant Limited, the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment from Mercia Technologies PLC.

Wed 22 May 2019, 09:14 | Tags: Warwick Ventures, Life Sciences and Biotechnology, spinout

Older news